| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |